A new study demonstrates that an artificial intelligence algorithm can analyze intravascular images to predict recurrent heart attacks more accurately than human experts, paving the way for automated cardiovascular risk...
Most Recent Articles
REBOOT Trial Analysis Reveals Sex-Specific Harm of Beta-Blockers Post-MI in Women
A major clinical trial reveals that beta-blocker therapy after a heart attack may be harmful to women with preserved heart function, challenging standard treatment guidelines.
AI-Enabled Stethoscope Increases Cardiac Diagnoses in Primary Care: Findings from the TRICORDER Trial
A landmark UK trial demonstrates that an AI-enabled stethoscope can more than double the detection rate of heart failure in primary care, enabling earlier diagnosis and treatment for patients.
REBOOT Trial: Beta-Blockers Show No Benefit Post-MI in Patients with Preserved Ejection Fraction
The REBOOT trial finds beta-blockers offer no benefit after uncomplicated heart attacks with preserved cardiac function, challenging a decades-old treatment paradigm and suggesting a need to update clinical guidelines.
Development and Psychometric Validation of the PLATO-11 for Clinical Monitoring of OSA
Discover PLATO-11, a new, validated 11-item questionnaire for efficiently tracking patient-reported symptoms and treatment response in adults with obstructive sleep apnea.